RBC Capital Markets analyst Leonid Timashev increased the price target for Axsome Therapeutics (NASDAQ:AXSM) to $143 from $139, while keeping an Outperform rating on the stock. According to ...

In a report released today, Nik Modi from RBC Capital reiterated a Hold rating on Colgate-Palmolive (CL – Research Report), with a price target ...

RBC Capital analyst Tom Narayan maintained a Buy rating on Tesla (TSLA – Research Report) today and set a price target of $440.00. The ...

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his ...

RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...

J.M. Smucker Co. chief executive Mark Smucker leaned on close advisers when he made the decision to bolster the jelly and ...

Markets sold off on Monday as investors digested Donald Trump's tariff announcements on Mexico, Canada and China.

Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA:ESLX) to "outperform," citing strong fundamentals and growth opportunities in the ophthalmology sector. Shares of the ...

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...

Investing.com -- RBC Capital Markets lowered its price target for Nike Inc (NYSE:NKE) to $70 from $80 on the prolonged challenges in the company’s turnaround efforts. While the brokerage ...

Microsoft's disappointing Azure numbers are "neutral to modestly negative" for rivals Amazon.com and Alphabet, according to RBC Capital Markets analyst Brad Erickson. Alphabet stock rose 1% while ...

Find insight on United Utilities, Viva Energy, Valero Energy and more in the latest Market Talks covering Energy and ...